Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness
Veterinary Radiology & Ultrasound · 2024
DOI: 10.1111/vru.13361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Radiology & Ultrasound, 2024. Verfasst von Tiffany W Martin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Fluorodeoxyglucose F18, Dog Diseases, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lucy and Friends PET/CT Support Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Serial fluorine 18 fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography–CT (PET/CT) is commonly used in human oncology to prognosticate and evaluate for therapeutic effectiveness. In this pilot study, dogs with naturally occurring appendicular osteosarcoma were evaluated with serial 18 F‐FDG PET/CT in an attempt to assess for response to therapy, prognostic factors, and appropriateness of imaging intervals. Fourteen dogs were enrolled in the trial. All dogs had the initial 18 F‐FDG PET/CT (PET1), with nine dogs having their end‐of‐therapy 18 F‐FDG PET/CT (EoT PET) 3 months after stereotactic body radiation therapy (SBRT) to the primary tumor. The median percent change from the PET1 to the EoT PET for the standard uptake value maximum (SUV max% ) was −58% (range: −17 to −88%), metabolic tumor volume (MTV % ) was −99.8% (range: −65 to −100%), and total lesion glycolysis (TLG % ) was −99.8% (range: −75 to −100%), all of which were significant ( P < .05,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, USA.
- VCA Canada Central Victoria Veterinary Hospital, Victoria, British Columbia, Canada.
ORCID-Profile: Tiffany W Martin, Lynn Griffin
Förderung
- Lucy and Friends PET/CT Support Fund
Zitieren
APA
Martin, T. W., & Griffin, L. (2024). Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness. Veterinary Radiology & Ultrasound. https://doi.org/10.1111/vru.13361
Vancouver
Martin TW, Griffin L. Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness. Veterinary Radiology & Ultrasound. 2024. doi:10.1111/vru.13361
BibTeX
@article{Martin2024,
author = {Martin, Tiffany W and Griffin, Lynn},
title = {Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness},
journal = {Veterinary Radiology & Ultrasound},
year = {2024},
doi = {10.1111/vru.13361}
}
EUVIMED